GSK to Invest $30B in Drug Manufacturing and R&D in the US
GSK plc has unveiled a plan to invest $30 billion into research, development and supply chain infrastructure across the United ...
GSK plc has unveiled a plan to invest $30 billion into research, development and supply chain infrastructure across the United ...
The US FDA approves Sanofi’s Wayrilz (rilzabrutinib) for use in adult patients with chronic or persistent immune thrombocytopenia (ITP) who ...
Genentech, part of the Roche Group, has broken ground on its latest US manufacturing facility in Holly Springs, North Carolina. ...
NORTH CHICAGO, Ill. and NEW YORK, Aug. 25, 2025 -- AbbVie and Gilgamesh Pharmaceuticals Inc. ("Gilgamesh") announced a definitive agreement ...
Pharmaceutical tariffs between the European Union and the United States will now be limited at 15% under the terms of ...
The U.S. Food and Drug Administration granted approval for Papzimeos (zopapogene imadenovec-drba), marking the introduction of a first-of-its-kind, non-replicating adenoviral ...
US President Donald Trump has instructed the Department of Health and Human Services (HHS) to compile a list of essential ...
The U.S. Food and Drug Administration, FDA approves Brinsupri, Insmed's oral drug for a lung disease, the company announced. This ...
The Food and Drug Administration has launched a new initiative aimed at boosting drug manufacturing within the United States. This ...
The U.S. Food and Drug Administration has officially approved a new brain tumour treatment developed by Jazz Pharmaceuticals. The medication, ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.